---

---

symbols : GSK    crawled time : 11:00   

save search

---

Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
Published: 2023-10-27 (Crawled : 11:00) - globenewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 14.52% | O: -0.7% H: 0.0% C: -2.46%
ALEC | $5.27 -1.31% -1.33% 380K |

Health Technology

| -0.57% | O: 0.76% H: 0.38% C: -3.57%
dementia trial

---

CureVac berichtet über Fortschritt im Verfahren der Verletzung geistigen Eigentums gegen BioNTech in Deutschland
Published: 2023-09-28 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.65% | O: -3.04% H: 2.1% C: 2.1%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 10.31% | O: -0.94% H: 0.44% C: -0.95%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -64.7% | O: 2.53% H: 1.99% C: -10.84%

---

Mersana Therapeutics Announces Changes in Leadership
Published: 2023-09-06 (Crawled : 11:00) - globenewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 18.23% | O: 0.12% H: 0.06% C: -0.55%
MRSN | $2.89 -9.97% -11.07% 3.2M |

Health Technology

| 152.63% | O: 0.0% H: 9.65% C: 7.89%
therapeutics

---

Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
Published: 2023-08-21 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 16.76% | O: 0.0% H: 0.68% C: 0.68%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 18.54% | O: 0.26% H: 0.23% C: -0.03%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 37.04% | O: 2.54% H: 0.0% C: 0.0%
FOLD 4 | $10.52 -1.77% -1.81% 1.6M |

Health Technology

| -17.2% | O: 0.71% H: 0.66% C: -1.56%
therapeutics financial simon

---

Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 17.73% | O: 5.46% H: 0.0% C: -2.87%
NVSEF | News | $96.0 6.88% 52K |

Health Technology

| 11.1% | O: -0.67% H: 0.0% C: 0.0%
VTRS | News A | $11.55 1.67% 1.65% 7.2M |

Health Technology

| 3.49% | O: -0.99% H: 1.45% C: 1.36%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| -4.13% | O: -0.2% H: 0.34% C: -0.26%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 15.88% | O: -0.77% H: 0.79% C: 0.17%
BAX | $40.93 -0.22% 0.0% 2.2M |

Health Technology

| -3.35% | O: -0.4% H: 0.73% C: -0.24%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 10.66% | O: 0.56% H: 0.0% C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 0.94% | O: -1.36% H: 0.88% C: 0.07%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -12.42% | O: -1.33% H: 0.0% C: 0.0%
disease market

---

GSK Grants LimmaTech Biologics License to Develop and Commercialize Shigella Vaccine
Published: 2023-07-20 (Crawled : 11:00) - biospace.com/
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 16.11% | O: 1.19% H: 0.42% C: 0.25%
vaccine license grants

---

Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio
Published: 2023-07-14 (Crawled : 11:00) - prnewswire.com
CSLLY | $90.71 3.3% 35K |

n/a

| -0.87% | O: -0.54% H: 0.0% C: -1.4%
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 12.46% | O: 0.0% H: 1.42% C: 0.96%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| 1.31% | O: 6.03% H: -2.14% C: -2.14%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -34.73% | O: 0.96% H: 0.0% C: -1.71%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 17.41% | O: 0.03% H: 0.2% C: -0.8%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| -0.79% | O: 0.24% H: 0.44% C: -0.06%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -11.25% | O: 0.36% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 5.15% | O: 1.79% H: 0.0% C: -2.23%
pharma vaccine research market

---

CureVac veröffentlicht Finanzergebnisse für das erste Quartal 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-05-30 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 17.39% | O: -1.3% H: 0.36% C: 0.36%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 19.33% | O: 0.18% H: 0.0% C: -1.28%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -72.57% | O: 0.0% H: 1.64% C: -3.06%

---

CureVac gibt Entwicklungen im Patentrechtsstreit mit Pfizer/BioNTech bekannt
Published: 2023-05-19 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 10.28% | O: -1.67% H: 1.53% C: 0.28%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 16.05% | O: -0.14% H: 1.45% C: 1.28%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -71.35% | O: 0.91% H: 4.53% C: 2.49%
BNTX | News | $88.18 -0.35% -0.35% 280K |

Health Technology

| -16.06% | O: 0.37% H: 1.96% C: 1.09%

---

Zentalis Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Updates
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 7.88% | O: -1.66% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 12.1% | O: -0.03% H: 0.38% C: 0.25%
ZNTL | $11.76 -6.44% -6.89% 850K |

Health Technology

| -48.4% | O: 2.59% H: 4.49% C: 4.23%
pharmaceuticals financial results

---

CureVac gibt Impfung des ersten Teilnehmers in kombinierter Phase 1/2-Studie für multivalente, modifizierte Grippe-Impfstoffkandidaten bekannt, entwickelt in Zusammenarbeit mit GSK
Published: 2023-05-08 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 6.15% | O: 4.81% H: 0.0% C: -6.12%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 10.49% | O: 0.24% H: 0.3% C: -0.81%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -69.54% | O: 0.0% H: 4.98% C: 2.55%

---

CureVac veröffentlicht Finanzergebnisse für das vierte Quartal sowie das Gesamtjahr 2022 und informiert über seine Geschäftsentwicklung
Published: 2023-04-25 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 8.77% | O: 0.22% H: 4.05% C: 4.05%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 11.49% | O: 1.64% H: 0.19% C: -0.91%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -67.32% | O: -1.3% H: 2.24% C: -4.35%

---

CureVac veröffentlicht am 25. April 2023 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2022 und informiert über seine Geschäftsentwicklung
Published: 2023-04-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 1.59% | O: -6.76% H: 3.18% C: 1.34%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 9.28% | O: -0.64% H: 0.23% C: -1.0%
CVAC | $2.51 -3.46% -3.59% 1.1M |

Health Technology

| -68.39% | O: 0.13% H: 1.13% C: 0.0%

---

United Kingdom Over The Counter (OTC) Drugs Markets, Competition Forecast & Opportunities, 2027: Generics, Investments and Expenses & Expanding Pharmaceutical Industry Promises Market Growth
Published: 2023-04-04 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 13.23% | O: 2.17% H: 0.0% C: 0.0%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -1.56% | O: 3.16% H: 0.0% C: -0.28%
PRGO | $31.23 2.43% 0.0% 960K |

Health Technology

| -12.86% | O: 0.14% H: 0.08% C: -0.11%
JNJ | News | $148.53 -0.69% -0.14% 9.6M |

Health Technology

| -5.3% | O: 0.08% H: 1.27% C: 0.97%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 13.66% | O: 0.64% H: 1.11% C: 1.02%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 1.85% | O: 0.1% H: 0.84% C: 0.39%
investments growth market

---

Dermatitis Global Market Research Report 2023: An $8.57 Billion Market by 2027 - Long-term Forecasts to 2032
Published: 2023-03-20 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 17.94% | O: 1.07% H: 0.0% C: -0.06%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -1.13% | O: 0.98% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K |

Manufacturing

| -31.77% | O: -0.5% H: 1.38% C: 1.23%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 19.66% | O: 0.78% H: 0.74% C: 0.72%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 19.93% | O: 1.38% H: 1.16% C: 1.13%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 8.81% | O: 0.19% H: 1.18% C: 1.04%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.16% | O: 0.4% H: 0.0% C: 0.0%
report dermatitis research global market

---

Vitamin and Minerals Global Market Report 2023: A $24.69 Billion Industry by 2026 - Long-term Forecast to 2032
Published: 2023-02-24 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 14.15% | O: 1.61% H: 0.0% C: -0.4%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -3.19% | O: -2.11% H: 0.0% C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 15.88% | O: -1.13% H: 0.11% C: -0.83%
ABT | News | $106.89 -0.65% -0.22% 5.1M |

Health Technology

| 4.23% | O: -1.07% H: 0.34% C: -0.98%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -1.91% | O: 0.72% H: 0.0% C: 0.0%
global report market

---

Blow Fill Seal Technology Global Market Report 2023: Growing Demand from the Food and Beverage Industry Bolsters Sector
Published: 2023-02-23 (Crawled : 11:00) - prnewswire.com
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 14.33% | O: -1.45% H: 0.57% C: 0.11%
CTLT | $55.95 -0.14% 0.0% 2M |

Health Technology

| -17.31% | O: 0.35% H: 0.88% C: -0.37%
global report growing technology food market

---

Insights on the Pharmaceutical API Manufacturing Global Market to 2032: North America was the Largest Region in 2022
Published: 2023-02-22 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 11.52% | O: 0.48% H: 0.0% C: -2.77%
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| 0.0% | O: 0.53% H: 1.82% C: 1.82%
AZNCF | News | $140.3 -4.19% 1.5K |

Health Technology

| -3.68% | O: -0.48% H: 0.14% C: 0.14%
NVS | News | $98.35 1.1% 0.0% 2.2M |

Health Technology

| 13.36% | O: 0.98% H: 0.03% C: -1.06%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 13.5% | O: 0.19% H: 0.0% C: -0.91%
LLY | News | $732.2 -1.81% 0.18% 2.1M |

Health Technology

| 123.57% | O: 0.37% H: 1.18% C: 0.11%
ALB | News | $115.27 0.93% -0.23% 2.2M |

Process Industries

| -52.36% | O: 0.43% H: 1.9% C: 1.42%
ABBV | News | $167.8 -1.03% -0.06% 4.1M |

Health Technology

| 10.39% | O: -0.66% H: 0.76% C: -0.22%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -2.35% | O: 0.54% H: 0.0% C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M |

Health Technology

| 2.31% | O: 0.04% H: 0.04% C: -1.11%
america global market

---

SpyBiotech Appoints Industry Veteran Eddie Gray as Chair of its Board of Directors
Published: 2023-02-13 (Crawled : 11:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K |

Health Technology

| 9.25% | O: -1.73% H: 0.0% C: -1.43%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 14.01% | O: 0.61% H: 0.47% C: 0.47%

---

Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $94.25 -2.18% 480 |

Health Technology

| -4.57% | O: -0.27% H: 0.1% C: 0.1%
NTRB | $3.56 -8.76% 3.4K |

Manufacturing

| 9.69% | O: -2.85% H: 0.0% C: -1.76%
RANI | $6.87 2.69% 2.62% 140K |

| 9.91% | O: -1.1% H: 1.91% C: -3.82%
MRK | $127.0 0.1% -1.21% 7.1M |

Health Technology

| 15.58% | O: 0.11% H: 0.0% C: -1.35%
GSK | News | $40.86 -0.92% -0.15% 1.7M |

Health Technology

| 15.55% | O: -1.02% H: 0.0% C: -0.86%
SNY | News | $46.66 -2.16% -2.21% 1.7M |

Health Technology

| -4.59% | O: -0.72% H: 0.0% C: 0.0%
conference transdermal

---

Gainers vs Losers

62%

38%

Top 10 Gainers

CSSE 4 | $0.4323 183.85% 64.77% 220M |

Consumer Services

BOF | $1.99 70.09% 41.21% 110M |

ILAG | $0.51 6.03% 40.62% 1.7M |

LICN | $0.941 68.04% 40.49% 15M |

AMST | $3.31 65.5% 39.58% 70M |

Technology Services

MTC | $3.615 61.38% 38.04% 9.3M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.45 12.5% 30.92% 320K |

Health Services

MULN | News | $3.78 38.46% 27.78% 13M |

Information

RILY | $29.86 37.48% 27.26% 12M |

Finance

---

Your saved searches

---